B2-M being a potentially prognostic risk factor for AITL, the possible mechanisms are as follows: on the one hand, β2-M participates in immune recognition and loss of functional β2-M through genomic alterations or other yet uncharacterized mechanisms leads to lack of HLA-I expression and escape from CTL11. This evidence concerns the gene B2M and angioimmunoblastic T-cell lymphoma.